Downregulation of TNF-α/TNF-R1 Signals by AT-Lipoxin A4 May Be a Significant Mechanism of Attenuation in SAP-Associated Lung Injury

Abstract

Our previous studies verified the potent anti-inflammatory effects against severe acute pancreatitis (SAP) of AT-Lipoxin A4 and their analogues. However, the anti-inflammatory effects of AT-Lipoxin A4 on SAP-associated lung injury are not thoroughly known. We used western blot, polymerase chain reaction (PCR), and immunofluorescence to investigate the downregulation of TNF-α signals in cellular and animal models of SAP-associated lung injury following AT-Lipoxin A4 intervention. In vitro, we found that AT-Lipoxin A4 markedly suppressed protein expression in TNF-α signals in human pulmonary microvascular endothelial cell, such as tumor necrosis factor receptor-associated factor 2 (TRAF2), TNF-R1-associated death domain (TRADD), receptor-interacting protein (RIP), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin. Moreover, AT-Lipoxin A4 inhibited downstream signals activated by TNF-α, including NF-κB/p65, JNK/MAPK, and ERK/MAPK. In vivo, AT-Lipoxin A4 significantly decreased pathological scores of the pancreas and lungs and the serum levels of IL-6 and TNF-α. Immunofluorescence, western blotting, and real-time PCR assay showed that AT-Lipoxin A4 significantly attenuated the expression of TNF-R1, TRADD, TRAF2, and RIP in the lungs of SAP rats. In addition, the activation of NF-κB was also downregulated by AT-Lipoxin A4 administration as compared with SAP rats. AT-Lipoxin A4 could inhibit the production of proinflammatory mediators and activation of TNF-α downstream signals such as NF-κB and MAPK. Downregulation of TNF-α signals by AT-Lipoxin A4 may be a significant mechanism in the attenuation of SAP-associated lung injury.

Electroacupuncture pre‑conditioning protects from lung injury induced by limb ischemia/reperfusion through TLR4 and NF‑κB in rats

“…TnF-α is a key mediator of acute lung injury, acute respiratory distress syndrome and early lung tissue injury (26). during the lung injury process, TnF-α is primarily produced by alveolar macrophages, which can mobilize polymorphonuclear leukocytes in the blood to accumulate at lung injury sites, thus activating inflammatory cells and endothelial cells, and supporting the formation of factors such as endothelial cells and neutrophils that increase the expression levels of IL-1, IL-6 and IL-8 (27).…”

The role of TRPV1 channels in atherosclerosis

“…Mechanisms underlying these increased expression levels may include the following: activation of TRPV1 downregulates epidermal growth factor receptor (EGFR) levels by inducing its ubiquitination and degradation, thereby inhibiting the EGFR/mitogen-activated protein kinases (MAPKs) pathway. MAPKs are a group of serine/ threonine protein kinases composed of multiple isoenzymes (ERK, P38, and JNK) [45]. Inhibition of any of the three enzymes reduces the expression levels of cytokines and adhesion molecules [46], especially those involved in the ERK pathway, which is closely related to various inflammatory responses [47].…”

Mir-331-3p Inhibits PRRSV-2 Replication and Lung Injury by Targeting PRRSV-2 ORF1b and Porcine TNF-α

“…Yang et al (52) demonstrated that TNF-α might be a major contributor in ii/r-induced lung injury, and that the knockdown of TNF-α alleviated the severity of lung injury. Yu et al (53) reported that downregulation of TNF-α signals by AT-Lipoxin A4 might be a significant mechanism in the attenuation in severe acute pancreatitis-associated lung injury. Our study also indicated that mir-331-3p inhibited the expression of TNF-α by directly targeting its 3 ′ UTR.…”